An update on the therapeutic implications of long-chain acyl-coenzyme A synthetases in nervous system diseases

Long-chain acyl-coenzyme A synthetases (ACSLs) are a family of CoA synthetases that activate fatty acid (FA) with chain lengths of 12–20 carbon atoms by forming the acyl-AMP derivative in an isozyme-specific manner. This family mainly includes five members (ACSL1, ACSL3, ACSL4, ACSL5, and ACSL6), wh...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in neuroscience Vol. 16; p. 1030512
Main Authors Wu, Zhimin, Sun, Jun, Liao, Zhi, Qiao, Jia, Chen, Chuan, Ling, Cong, Wang, Hui
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 24.11.2022
Subjects
fatty acid (FA) metabolism
ferroptosis
long-chain acyl-coenzyme A synthetases (ACSLs)
nervous system diseases
Neuroscience
targeted therapy
long-chain acyl-coenzyme A synthetases (ACSLs)
nervous system diseases
targeted therapy
fatty acid (FA) metabolism
ferroptosis
Online AccessGet full text

Cover

Abstract Long-chain acyl-coenzyme A synthetases (ACSLs) are a family of CoA synthetases that activate fatty acid (FA) with chain lengths of 12–20 carbon atoms by forming the acyl-AMP derivative in an isozyme-specific manner. This family mainly includes five members (ACSL1, ACSL3, ACSL4, ACSL5, and ACSL6), which are thought to have specific and different functions in FA metabolism and oxidative stress of mammals. Accumulating evidence shows that the dysfunction of ACSLs is likely to affect cell proliferation and lead to metabolic diseases in multiple organs and systems through different signaling pathways and molecular mechanisms. Hence, a central theme of this review is to emphasize the therapeutic implications of ACSLs in nervous system disorders.
AbstractList Long-chain acyl-coenzyme A synthetases (ACSLs) are a family of CoA synthetases that activate fatty acid (FA) with chain lengths of 12–20 carbon atoms by forming the acyl-AMP derivative in an isozyme-specific manner. This family mainly includes five members (ACSL1, ACSL3, ACSL4, ACSL5, and ACSL6), which are thought to have specific and different functions in FA metabolism and oxidative stress of mammals. Accumulating evidence shows that the dysfunction of ACSLs is likely to affect cell proliferation and lead to metabolic diseases in multiple organs and systems through different signaling pathways and molecular mechanisms. Hence, a central theme of this review is to emphasize the therapeutic implications of ACSLs in nervous system disorders.
Long-chain acyl-coenzyme A synthetases (ACSLs) are a family of CoA synthetases that activate fatty acid (FA) with chain lengths of 12-20 carbon atoms by forming the acyl-AMP derivative in an isozyme-specific manner. This family mainly includes five members (ACSL1, ACSL3, ACSL4, ACSL5, and ACSL6), which are thought to have specific and different functions in FA metabolism and oxidative stress of mammals. Accumulating evidence shows that the dysfunction of ACSLs is likely to affect cell proliferation and lead to metabolic diseases in multiple organs and systems through different signaling pathways and molecular mechanisms. Hence, a central theme of this review is to emphasize the therapeutic implications of ACSLs in nervous system disorders.Long-chain acyl-coenzyme A synthetases (ACSLs) are a family of CoA synthetases that activate fatty acid (FA) with chain lengths of 12-20 carbon atoms by forming the acyl-AMP derivative in an isozyme-specific manner. This family mainly includes five members (ACSL1, ACSL3, ACSL4, ACSL5, and ACSL6), which are thought to have specific and different functions in FA metabolism and oxidative stress of mammals. Accumulating evidence shows that the dysfunction of ACSLs is likely to affect cell proliferation and lead to metabolic diseases in multiple organs and systems through different signaling pathways and molecular mechanisms. Hence, a central theme of this review is to emphasize the therapeutic implications of ACSLs in nervous system disorders.
Author Liao, Zhi
Ling, Cong
Wang, Hui
Sun, Jun
Chen, Chuan
Qiao, Jia
Wu, Zhimin
AuthorAffiliation 1 Department of Neurosurgery, The Third Affiliated Hospital, Sun Yat-sen University , Guangzhou, Guangdong , China
2 Department of Rehabilitation Medicine, The Third Affiliated Hospital, Sun Yat-sen University , Guangzhou, Guangdong , China
AuthorAffiliation_xml – name: 2 Department of Rehabilitation Medicine, The Third Affiliated Hospital, Sun Yat-sen University , Guangzhou, Guangdong , China
– name: 1 Department of Neurosurgery, The Third Affiliated Hospital, Sun Yat-sen University , Guangzhou, Guangdong , China
Author_xml – sequence: 1
  givenname: Zhimin
  surname: Wu
  fullname: Wu, Zhimin
– sequence: 2
  givenname: Jun
  surname: Sun
  fullname: Sun, Jun
– sequence: 3
  givenname: Zhi
  surname: Liao
  fullname: Liao, Zhi
– sequence: 4
  givenname: Jia
  surname: Qiao
  fullname: Qiao, Jia
– sequence: 5
  givenname: Chuan
  surname: Chen
  fullname: Chen, Chuan
– sequence: 6
  givenname: Cong
  surname: Ling
  fullname: Ling, Cong
– sequence: 7
  givenname: Hui
  surname: Wang
  fullname: Wang, Hui
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36507355$$D View this record in MEDLINE/PubMed
BookMark eNp9kslqHDEQhkVwiJfkBXIIOubSYy0tdesSGEwWgyGXBHITGqk0I9MtdaQew-Tpo1ls7BxyEBJV9X9Fqf5LdBZTBITeU7LgvFfXPoZYFowwtqCEE0HZK3RBpWRNK_ivs2fvc3RZyj0hkvUte4POuRSk40JcoLiMeDs5MwNOEc8b2J9sJtjOweIwTkOwZg4pFpw8HlJcN3ZjQsTG7obGJoh_diPgJS67WJWzKVBwTUfID2lbarjMMGIXCuxTb9Frb4YC7073Ffr55fOPm2_N3fevtzfLu8a2sp8bYB5a5XtPjHAEqFNUCtcpyp1ZMU-U61rXW2Ic99RQQ7xkUraGK8UJkx2_QrdHrkvmXk85jCbvdDJBHwIpr7XJdcIBdGeUF51n1PK2bSVZCd4JT1i_glZSyirr05E1bVcjOAtxzmZ4AX2ZiWGj1-lBq45TylUFfDwBcvq9hTLrMRQLw2Ai1D_SrBNcyl71vJZ-eN7rqcnjwmpBfyywOZWSwWsb5sOCauswaEr03hv64A2994Y-eaNK2T_SR_p_RH8B756_3Q
CitedBy_id crossref_primary_10_1002_ctm2_1180
crossref_primary_10_1016_j_npep_2024_102475
crossref_primary_10_1002_advs_202303570
crossref_primary_10_1007_s11010_024_05150_6
crossref_primary_10_1186_s12915_024_01879_0
crossref_primary_10_1210_endocr_bqad043
crossref_primary_10_1002_anie_202500518
crossref_primary_10_1002_ange_202500518
crossref_primary_10_1016_j_expneurol_2024_115053
crossref_primary_10_1016_j_expneurol_2025_115172
Cites_doi 10.1038/s41418-019-0299-4
10.1093/jn/138.12.2515
10.1042/BSR20193314
10.1146/annurev-nutr-071813-105541
10.3390/ijms20153624
10.1194/jlr.S091843
10.1016/j.celrep.2020.108323
10.1016/j.cell.2022.06.003
10.1038/s41467-020-19193-y
10.1016/j.freeradbiomed.2022.05.023
10.1038/s41420-021-00698-4
10.1016/j.psychres.2017.04.048
10.1111/bdi.12220
10.1021/jacs.1c08254
10.1093/oxfordjournals.jbchem.a021731
10.1016/j.brainresbull.2021.06.014
10.1096/fj.202002621RR
10.3748/wjg.v21.i12.3492
10.1093/hmg/ddl409
10.1111/febs.12546
10.1111/j.1601-183X.2006.00251.x
10.1053/j.gastro.2007.06.005
10.1007/s11011-022-00983-w
10.3892/ol.2018.8843
10.3389/fncel.2021.632354
10.1371/journal.pone.0214250
10.1126/sciadv.abd9036
10.1038/s41401-021-00635-2
10.1080/21655979.2021.1951070
10.1177/17590914211010647
10.1186/s13041-019-0501-0
10.1155/2022/8279851
10.3389/fnins.2019.00512
10.1016/j.ejphar.2021.174397
10.1007/s11010-021-04138-w
10.1073/pnas.1703791114
10.1111/jcmm.17241
10.1016/j.prostaglandins.2019.106363
10.3892/mmr_00000155
10.1016/j.jsbmb.2020.105792
10.3389/fonc.2022.841418
10.1002/ajmg.a.33208
10.1074/jbc.271.28.16748
10.1186/s13195-017-0295-1
10.1242/jcs.195032
10.1038/s42003-020-01251-2
10.1371/journal.pone.0028790
10.1523/JNEUROSCI.3278-10.2011
10.1016/j.phrs.2021.105933
10.1172/jci.insight.144351
10.1016/j.chembiol.2018.11.016
10.1021/bi047721l
10.1016/j.molcel.2012.04.033
10.21037/atm-21-4249
10.3389/fgene.2021.750110
10.3892/ol.2020.11980
10.1111/cns.13548
10.1016/j.jgg.2018.10.006
10.1111/j.1349-7006.2009.01203.x
10.1038/s41598-022-10554-9
10.1002/ajmg.a.35778
10.1038/onc.2008.355
10.3181/0710-MR-287
10.1016/j.bbrc.2012.02.046
10.1186/s13041-022-00942-7
10.1073/pnas.1817557115
10.1038/s41556-021-00818-3
10.3389/fphar.2022.827016
10.1073/pnas.1807958115
10.3389/fonc.2022.888922
10.1016/j.isci.2021.102431
10.1007/s11064-021-03442-7
10.1155/2020/6687185
10.1038/s41580-020-00324-8
10.1093/hmg/ddp332
10.3389/fcell.2022.849854
10.3892/or.2019.7419
10.1074/jbc.M411750200
10.1194/jlr.M013292
10.1038/s41419-022-04997-1
10.1016/j.chembiol.2021.12.006
10.1155/2022/9069825
10.1080/10715762.2021.1962009
10.1016/j.intimp.2021.108002
10.1016/j.cbi.2022.110137
10.1194/jlr.M072512
10.1002/2211-5463.13203
10.1038/sj.onc.1203981
10.1016/j.pediatrneurol.2019.06.014
10.3892/ijmm.2021.4885
10.1038/s41389-020-00252-4
10.1016/j.neuroscience.2008.11.056
10.1016/j.freeradbiomed.2021.12.268
10.1038/s41392-022-00917-z
10.1007/s10072-022-05990-4
10.1021/acs.jproteome.8b00663
10.1038/nchembio.2239
10.1016/j.bbalip.2011.10.008
10.1097/CCM.0000000000003555
10.1158/1940-6207.CAPR-12-0304
10.1016/j.bbi.2021.01.003
10.1038/s41467-021-24469-y
10.1038/s41418-021-00910-z
10.7150/thno.26550
10.1016/j.tiv.2021.105146
10.1523/JNEUROSCI.3547-13.2014
10.3389/fmolb.2021.660072
10.1002/ejp.1737
10.1186/1471-2148-13-271
10.1073/pnas.1917946117
10.1016/j.jchemneu.2020.101807
10.1016/j.neulet.2020.135614
10.1038/s41418-021-00814-y
ContentType Journal Article
Copyright Copyright © 2022 Wu, Sun, Liao, Qiao, Chen, Ling and Wang.
Copyright © 2022 Wu, Sun, Liao, Qiao, Chen, Ling and Wang. 2022 Wu, Sun, Liao, Qiao, Chen, Ling and Wang
Copyright_xml – notice: Copyright © 2022 Wu, Sun, Liao, Qiao, Chen, Ling and Wang.
– notice: Copyright © 2022 Wu, Sun, Liao, Qiao, Chen, Ling and Wang. 2022 Wu, Sun, Liao, Qiao, Chen, Ling and Wang
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.3389/fnins.2022.1030512
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList CrossRef

MEDLINE - Academic

PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 1662-453X
ExternalDocumentID oai_doaj_org_article_7a9f57f21c344460b5375f028be46112
PMC9731139
36507355
10_3389_fnins_2022_1030512
Genre Journal Article
Review
GroupedDBID ---
29H
2WC
53G
5GY
5VS
8FE
8FH
9T4
AAFWJ
AAYXX
ABUWG
ACGFO
ACGFS
ACXDI
ADRAZ
AEGXH
AENEX
AFKRA
AFPKN
AIAGR
ALMA_UNASSIGNED_HOLDINGS
AZQEC
BBNVY
BENPR
BHPHI
BPHCQ
CITATION
CS3
DIK
DU5
E3Z
EBS
EJD
EMOBN
F5P
FRP
GROUPED_DOAJ
GX1
HCIFZ
HYE
KQ8
LK8
M2P
M48
M7P
O5R
O5S
OK1
OVT
P2P
PGMZT
PIMPY
PQQKQ
PROAC
RNS
RPM
W2D
88I
C1A
CCPQU
DWQXO
GNUQQ
IAO
IEA
IHR
ISR
M~E
NPM
7X8
5PM
ID FETCH-LOGICAL-c468t-e2fe49f8f0a5d0e1d9165d7913dab2f09d74d8c0ad3f1a1a0f62664a399302673
IEDL.DBID M48
ISSN 1662-453X
1662-4548
IngestDate Wed Aug 27 01:14:30 EDT 2025
Thu Aug 21 18:38:27 EDT 2025
Thu Jul 10 23:54:47 EDT 2025
Thu Jan 02 22:53:32 EST 2025
Tue Jul 01 01:39:48 EDT 2025
Thu Apr 24 22:52:33 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords long-chain acyl-coenzyme A synthetases (ACSLs)
nervous system diseases
targeted therapy
fatty acid (FA) metabolism
ferroptosis
Language English
License Copyright © 2022 Wu, Sun, Liao, Qiao, Chen, Ling and Wang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c468t-e2fe49f8f0a5d0e1d9165d7913dab2f09d74d8c0ad3f1a1a0f62664a399302673
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
This article was submitted to Neuropharmacology, a section of the journal Frontiers in Neuroscience
Edited by: Zhengwu Peng, Fourth Military Medical University, China
Reviewed by: Jeroen Bogie, University of Hasselt, Belgium; Caterina Bartolacci, University of Cincinnati, United States
These authors have contributed equally to this work
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fnins.2022.1030512
PMID 36507355
PQID 2753668983
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_7a9f57f21c344460b5375f028be46112
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9731139
proquest_miscellaneous_2753668983
pubmed_primary_36507355
crossref_citationtrail_10_3389_fnins_2022_1030512
crossref_primary_10_3389_fnins_2022_1030512
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-11-24
PublicationDateYYYYMMDD 2022-11-24
PublicationDate_xml – month: 11
  year: 2022
  text: 2022-11-24
  day: 24
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in neuroscience
PublicationTitleAlternate Front Neurosci
PublicationYear 2022
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Meloni (B63) 2009; 159
Wright (B97) 2017; 114
Tan (B86) 2020; 20
Zhang (B110) 2009; 18
Ben-Zaken (B4) 2022; 43
Marszalek (B60) 2005; 280
Zhu (B113) 2022; 43
Doll (B20) 2017; 13
Liu (B56) 2011; 31
Chen (B11) 2006; 15
Bao (B2) 2021; 55
Wang (B91) 2021; 476
Saez-Atienzar (B79) 2021; 7
Hu (B35) 2022; 2022
Jia (B39) 2019; 46
An (B1) 2022; 47
Xiao (B98) 2019; 12
Jiang (B40) 2021; 22
Grevengoed (B30) 2014; 34
Quan (B75) 2021; 909
Rodriguez (B77) 2010
Chouinard-Watkins (B15) 2018; 115
Huang (B36) 2016; 129
Chen (B9) 2021; 15
Wang (B93) 2022; 187
Gazou (B28) 2013
Nakahara (B68) 2012; 46
Mao (B59) 2019; 13
Golej (B29) 2011; 52
Peng (B71) 2021; 174
Zhang (B108) 2022; 24
Yi (B106) 2020; 40
Pontifex (B72) 2021; 35
Shao (B81) 2020; 117
Cui (B18) 2021; 93
Li (B52) 2019; 26
Zhang (B109) 2022; 13
Kahn-Kirby (B42) 2019; 14
Li (B51) 2021; 73
Tuo (B89) 2022; 7
Gao (B25) 2022; 26
Gubern (B31) 2013; 280
Iacoangeli (B38) 2020; 33
Modi (B65) 2014; 16
Chen (B10) 2022; 179
Liang (B53) 2022; 15
Kim (B45) 2009; 2
Zilka (B114) 2021; 143
Guo (B32) 2021; 47
Mashima (B62); 28
Song (B83) 2021; 24
Li (B49) 2021; 174
Zhou (B111) 2020; 107
Wang (B95) 2022; 29
Thomas (B88) 2017; 9
Chang (B6) 2019; 100
Kuwata (B48) 2019; 144
Pang (B70) 2022; 10
Yuan (B107) 2022; 2022
Cheng (B12) 2020; 43
Qu (B74) 2021; 27
Guo (B33) 2021; 25
Klett (B46) 2017; 58
Coleman (B17) 2019; 60
Stockwell (B85) 2022; 185
Shao (B80) 2022; 29
Smetana (B82) 2021; 12
Yamashita (B100) 2000; 19
Cheng (B13) 2021; 9
Chang (B5) 2021; 8
Gao (B26) 2021; 99
Chen (B7) 2021; 12
Kenny (B44) 2019; 47
Li (B50) 2022; 366
Wei (B96) 2021; 11
Rossi Sebastiano (B78) 2019; 20
Tang (B87) 2018; 16
Mashima (B61); 100
Gassler (B27) 2007; 133
Van Horn (B90) 2005; 44
Miao (B64) 2022; 13
Yee (B105) 2020; 11
Yang (B103) 2020; 2020
Zhou (B112) 2019; 18
Yao (B104) 2021; 747
Jin (B41) 2021; 13
Cho (B14) 2012; 419
Qiu (B73) 2020; 9
Fujino (B23) 1996; 271
Wang (B94) 2018; 8
Wang (B92) 2013; 6
Fujino (B24) 1997; 122
Moujalled (B67) 2021; 28
Soupene (B84) 2008; 233
Fernandez (B22) 2021; 6
Kanter (B43) 2012; 1821
Xu (B99) 2022; 12
Chen (B8) 2011; 6
Nakamura (B69) 2020; 3
Chowdari (B16) 2007; 6
Magtanong (B58) 2019; 26
Dattilo (B19) 2021; 208
Fernandez (B21) 2018; 115
Hacioglu (B34) 2022
Yan (B102) 2015; 21
Liao (B54) 2021; 7
Liu (B55) 2014; 34
Lopes-Marques (B57) 2013; 13
Huang (B37) 2022; 11
Kram (B47) 2022; 12
Rapoport (B76) 2008; 138
Yan (B101) 2022; 12
Modi (B66) 2017; 254
Bao (B3) 2021; 12
References_xml – volume: 26
  start-page: 2284
  year: 2019
  ident: B52
  article-title: Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion.
  publication-title: Cell Death Differ.
  doi: 10.1038/s41418-019-0299-4
– volume: 138
  start-page: 2515
  year: 2008
  ident: B76
  article-title: Arachidonic acid and the brain.
  publication-title: J. Nutr.
  doi: 10.1093/jn/138.12.2515
– volume: 40
  year: 2020
  ident: B106
  article-title: Dihydroartemisinin initiates ferroptosis in glioblastoma through GPX4 inhibition.
  publication-title: Biosci. Rep.
  doi: 10.1042/BSR20193314
– volume: 34
  start-page: 1
  year: 2014
  ident: B30
  article-title: Acyl-CoA metabolism and partitioning.
  publication-title: Annu. Rev. Nutr.
  doi: 10.1146/annurev-nutr-071813-105541
– volume: 20
  year: 2019
  ident: B78
  article-title: Targeting long chain Acyl-CoA synthetases for cancer therapy.
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms20153624
– volume: 60
  start-page: 490
  year: 2019
  ident: B17
  article-title: It takes a village: Channeling fatty acid metabolism and triacylglycerol formation via protein interactomes.
  publication-title: J. Lipid Res.
  doi: 10.1194/jlr.S091843
– volume: 33
  year: 2020
  ident: B38
  article-title: Genome-wide meta-analysis finds the ACSL5-ZDHHC6 locus is associated with als and links weight loss to the disease genetics.
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2020.108323
– volume: 185
  start-page: 2401
  year: 2022
  ident: B85
  article-title: Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications.
  publication-title: Cell
  doi: 10.1016/j.cell.2022.06.003
– volume: 11
  year: 2020
  ident: B105
  article-title: Neutrophil-induced ferroptosis promotes tumor necrosis in glioblastoma progression.
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-020-19193-y
– volume: 187
  start-page: 171
  year: 2022
  ident: B93
  article-title: Irisin protects against sepsis-associated encephalopathy by suppressing ferroptosis via activation of the Nrf2/GPX4 signal axis.
  publication-title: Free Radic. Biol. Med.
  doi: 10.1016/j.freeradbiomed.2022.05.023
– volume: 7
  year: 2021
  ident: B54
  article-title: Cell death inhibitors protect against brain damage caused by cardiac ischemia/reperfusion injury.
  publication-title: Cell Death Discov.
  doi: 10.1038/s41420-021-00698-4
– volume: 254
  start-page: 279
  year: 2017
  ident: B66
  article-title: Valnoctamide, which reduces rat brain arachidonic acid turnover, is a potential non-teratogenic valproate substitute to treat bipolar disorder.
  publication-title: Psychiatry Res.
  doi: 10.1016/j.psychres.2017.04.048
– volume: 16
  start-page: 875
  year: 2014
  ident: B65
  article-title: Valnoctamide, a non-teratogenic amide derivative of valproic acid, inhibits arachidonic acid activation in vitro by recombinant acyl-CoA synthetase-4.
  publication-title: Bipolar Disord.
  doi: 10.1111/bdi.12220
– volume: 143
  start-page: 19043
  year: 2021
  ident: B114
  article-title: Radical-Trapping antioxidant activity of copper and nickel bis(Thiosemicarbazone) complexes underlies their potency as inhibitors of ferroptotic cell death.
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/jacs.1c08254
– volume: 122
  start-page: 212
  year: 1997
  ident: B24
  article-title: Alternative translation initiation generates acyl-CoA synthetase 3 isoforms with heterogeneous amino termini.
  publication-title: J. Biochem.
  doi: 10.1093/oxfordjournals.jbchem.a021731
– volume: 11
  year: 2022
  ident: B37
  article-title: Puerarin Attenuates oxidative stress and ferroptosis via AMPK/PGC1α/Nrf2 pathway after subarachnoid hemorrhage in rats.
  publication-title: Antioxidants (Basel)
– volume: 174
  start-page: 250
  year: 2021
  ident: B71
  article-title: N2L, a novel lipoic acid-niacin dimer, attenuates ferroptosis and decreases lipid peroxidation in HT22 cells.
  publication-title: Brain Res. Bull.
  doi: 10.1016/j.brainresbull.2021.06.014
– volume: 35
  year: 2021
  ident: B72
  article-title: APOE4 genotype exacerbates the impact of menopause on cognition and synaptic plasticity in APOE-TR mice.
  publication-title: FASEB J.
  doi: 10.1096/fj.202002621RR
– volume: 21
  start-page: 3492
  year: 2015
  ident: B102
  article-title: Long-chain acyl-CoA synthetase in fatty acid metabolism involved in liver and other diseases: An update.
  publication-title: World J. Gastroenterol.
  doi: 10.3748/wjg.v21.i12.3492
– volume: 15
  start-page: 3329
  year: 2006
  ident: B11
  article-title: Haplotypes spanning SPEC2, PDZ-GEF2 and ACSL6 genes are associated with schizophrenia.
  publication-title: Hum. Mol. Genet.
  doi: 10.1093/hmg/ddl409
– volume: 280
  start-page: 6233
  year: 2013
  ident: B31
  article-title: miRNA expression is modulated over time after focal ischaemia: Up-regulation of miR-347 promotes neuronal apoptosis.
  publication-title: FEBS J.
  doi: 10.1111/febs.12546
– volume: 6
  start-page: 229
  year: 2007
  ident: B16
  article-title: DNA pooling: A comprehensive, multi-stage association analysis of ACSL6 and SIRT5 polymorphisms in schizophrenia.
  publication-title: Genes Brain Behav.
  doi: 10.1111/j.1601-183X.2006.00251.x
– volume: 133
  start-page: 587
  year: 2007
  ident: B27
  article-title: Regulation of enterocyte apoptosis by acyl-CoA synthetase 5 splicing.
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2007.06.005
– year: 2022
  ident: B34
  article-title: Capsaicin induces redox imbalance and ferroptosis through ACSL4/GPx4 signaling pathways in U87-MG and U251 glioblastoma cells
  publication-title: Metab. Brain Dis
  doi: 10.1007/s11011-022-00983-w
– volume: 16
  start-page: 1390
  year: 2018
  ident: B87
  article-title: Fatty acid activation in carcinogenesis and cancer development: Essential roles of long-chain acyl-CoA synthetases.
  publication-title: Oncol. Lett.
  doi: 10.3892/ol.2018.8843
– volume: 15
  year: 2021
  ident: B9
  article-title: Inhibition of Acyl-CoA synthetase long-chain family member 4 facilitates neurological recovery after stroke by regulation ferroptosis.
  publication-title: Front. Cell. Neurosci.
  doi: 10.3389/fncel.2021.632354
– volume: 14
  year: 2019
  ident: B42
  article-title: Targeting ferroptosis: A novel therapeutic strategy for the treatment of mitochondrial disease-related epilepsy.
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0214250
– volume: 7
  year: 2021
  ident: B79
  article-title: Genetic analysis of amyotrophic lateral sclerosis identifies contributing pathways and cell types.
  publication-title: Sci. Adv.
  doi: 10.1126/sciadv.abd9036
– volume: 43
  start-page: 39
  year: 2022
  ident: B113
  article-title: Mitochondrial aldehyde dehydrogenase (ALDH2) rescues cardiac contractile dysfunction in an APP/PS1 murine model of Alzheimer’s disease via inhibition of ACSL4-dependent ferroptosis.
  publication-title: Acta Pharmacol. Sin.
  doi: 10.1038/s41401-021-00635-2
– volume: 12
  start-page: 4004
  year: 2021
  ident: B7
  article-title: Long non-coding RNA H19 protects against intracerebral hemorrhage injuries via regulating microRNA-106b-5p/acyl-CoA synthetase long chain family member 4 axis.
  publication-title: Bioengineered
  doi: 10.1080/21655979.2021.1951070
– volume: 13
  year: 2021
  ident: B41
  article-title: Paeonol inhibits the progression of intracerebral haemorrhage by mediating the HOTAIR/UPF1/ACSL4 axis.
  publication-title: ASN Neuro
  doi: 10.1177/17590914211010647
– volume: 12
  year: 2019
  ident: B98
  article-title: miR-212-5p attenuates ferroptotic neuronal death after traumatic brain injury by targeting Ptgs2.
  publication-title: Mol. Brain
  doi: 10.1186/s13041-019-0501-0
– volume: 2022
  year: 2022
  ident: B35
  article-title: Pomelo peel essential oil ameliorates cerebral ischemia-reperfusion injury through regulating redox homeostasis in rats and SH-SY5Y cells.
  publication-title: Oxid. Med. Cell. Longev.
  doi: 10.1155/2022/8279851
– volume: 13
  year: 2019
  ident: B59
  article-title: Redox-related neuronal death and crosstalk as drug targets: Focus on epilepsy.
  publication-title: Front. Neurosci.
  doi: 10.3389/fnins.2019.00512
– volume: 909
  year: 2021
  ident: B75
  article-title: ACSL family: The regulatory mechanisms and therapeutic implications in cancer.
  publication-title: Eur. J. Pharmacol.
  doi: 10.1016/j.ejphar.2021.174397
– volume: 476
  start-page: 3149
  year: 2021
  ident: B91
  article-title: Ferroptosis is involved in the development of neuropathic pain and allodynia.
  publication-title: Mol. Cell. Biochem.
  doi: 10.1007/s11010-021-04138-w
– volume: 114
  start-page: E6556
  year: 2017
  ident: B97
  article-title: CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation.
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
  doi: 10.1073/pnas.1703791114
– volume: 26
  start-page: 2191
  year: 2022
  ident: B25
  article-title: Overexpression of c-Jun inhibits erastin-induced ferroptosis in Schwann cells and promotes repair of facial nerve function.
  publication-title: J. Cell. Mol. Med.
  doi: 10.1111/jcmm.17241
– volume: 144
  year: 2019
  ident: B48
  article-title: Role of acyl-CoA synthetase ACSL4 in arachidonic acid metabolism.
  publication-title: Prostaglandins Other Lipid Mediat.
  doi: 10.1016/j.prostaglandins.2019.106363
– volume: 2
  start-page: 669
  year: 2009
  ident: B45
  article-title: RNA interference of long-chain acyl-CoA synthetase 6 suppresses the neurite outgrowth of mouse neuroblastoma NB41A3 cells.
  publication-title: Mol. Med. Rep.
  doi: 10.3892/mmr_00000155
– volume: 208
  year: 2021
  ident: B19
  article-title: Regulation and role of Acyl-CoA synthetase 4 in glial cells.
  publication-title: J. Steroid Biochem. Mol. Biol.
  doi: 10.1016/j.jsbmb.2020.105792
– volume: 12
  year: 2022
  ident: B47
  article-title: Glioblastoma relapses show increased markers of vulnerability to ferroptosis.
  publication-title: Front. Oncol.
  doi: 10.3389/fonc.2022.841418
– start-page: 713
  year: 2010
  ident: B77
  article-title: Intellectual disability, midface hypoplasia, facial hypotonia, and Alport syndrome are associated with a deletion in Xq22.3.
  publication-title: Am. J. Med. Genet. A
  doi: 10.1002/ajmg.a.33208
– volume: 271
  start-page: 16748
  year: 1996
  ident: B23
  article-title: Molecular characterization and expression of rat acyl-CoA synthetase 3.
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.271.28.16748
– volume: 9
  year: 2017
  ident: B88
  article-title: Dietary arachidonic acid increases deleterious effects of amyloid-β oligomers on learning abilities and expression of AMPA receptors: Putative role of the ACSL4-cPLA(2) balance.
  publication-title: Alzheimers Res. Ther.
  doi: 10.1186/s13195-017-0295-1
– volume: 129
  start-page: 4034
  year: 2016
  ident: B36
  article-title: Acsl, the Drosophila ortholog of intellectual-disability-related ACSL4, inhibits synaptic growth by altered lipids.
  publication-title: J. Cell Sci.
  doi: 10.1242/jcs.195032
– volume: 3
  year: 2020
  ident: B69
  article-title: A multi-ethnic meta-analysis identifies novel genes, including ACSL5, associated with amyotrophic lateral sclerosis.
  publication-title: Commun. Biol.
  doi: 10.1038/s42003-020-01251-2
– volume: 6
  year: 2011
  ident: B8
  article-title: ACSL6 is associated with the number of cigarettes smoked and its expression is altered by chronic nicotine exposure.
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0028790
– volume: 31
  start-page: 2052
  year: 2011
  ident: B56
  article-title: Drosophila Acyl-CoA synthetase long-chain family member 4 regulates axonal transport of synaptic vesicles and is required for synaptic development and transmission.
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.3278-10.2011
– volume: 174
  year: 2021
  ident: B49
  article-title: Nuclear receptor coactivator 4-mediated ferritinophagy contributes to cerebral ischemia-induced ferroptosis in ischemic stroke.
  publication-title: Pharmacol. Res.
  doi: 10.1016/j.phrs.2021.105933
– volume: 6
  year: 2021
  ident: B22
  article-title: Acyl-CoA synthetase 6 is required for brain docosahexaenoic acid retention and neuroprotection during aging.
  publication-title: JCI Insight
  doi: 10.1172/jci.insight.144351
– volume: 26
  start-page: 420
  year: 2019
  ident: B58
  article-title: Exogenous monounsaturated fatty acids promote a ferroptosis-resistant cell state.
  publication-title: Cell Chem. Biol.
  doi: 10.1016/j.chembiol.2018.11.016
– volume: 44
  start-page: 1635
  year: 2005
  ident: B90
  article-title: Characterization of recombinant long-chain rat acyl-CoA synthetase isoforms 3 and 6: Identification of a novel variant of isoform 6.
  publication-title: Biochemistry
  doi: 10.1021/bi047721l
– volume: 46
  start-page: 461
  year: 2012
  ident: B68
  article-title: The Sjögren-Larsson syndrome gene encodes a hexadecenal dehydrogenase of the sphingosine 1-phosphate degradation pathway.
  publication-title: Mol. Cell
  doi: 10.1016/j.molcel.2012.04.033
– volume: 9
  year: 2021
  ident: B13
  article-title: ACSL4 contributes to sevoflurane-induced ferroptotic neuronal death in SH-SY5Y cells via the 5’ AMP-activated protein kinase/mammalian target of rapamycin pathway.
  publication-title: Ann. Transl. Med.
  doi: 10.21037/atm-21-4249
– volume: 12
  year: 2021
  ident: B82
  article-title: Case report: Contiguous Xq22.3 deletion associated with ATS-ID syndrome: From genotype to further delineation of the phenotype.
  publication-title: Front. Genet.
  doi: 10.3389/fgene.2021.750110
– volume: 20
  year: 2020
  ident: B86
  article-title: Dihydrotanshinone I inhibits human glioma cell proliferation via the activation of ferroptosis.
  publication-title: Oncol. Lett.
  doi: 10.3892/ol.2020.11980
– volume: 27
  start-page: 449
  year: 2021
  ident: B74
  article-title: Acyl-CoA synthetase long chain family member 4 plays detrimental role in early brain injury after subarachnoid hemorrhage in rats by inducing ferroptosis.
  publication-title: CNS Neurosci. Ther.
  doi: 10.1111/cns.13548
– volume: 46
  start-page: 5
  year: 2019
  ident: B39
  article-title: Drosophila homolog of the intellectual disability-related long-chain acyl-CoA synthetase 4 is required for neuroblast proliferation.
  publication-title: J. Genet. Genom.
  doi: 10.1016/j.jgg.2018.10.006
– volume: 100
  start-page: 1556
  ident: B61
  article-title: Acyl-CoA synthetase as a cancer survival factor: Its inhibition enhances the efficacy of etoposide.
  publication-title: Cancer Sci.
  doi: 10.1111/j.1349-7006.2009.01203.x
– volume: 12
  year: 2022
  ident: B101
  article-title: Transcriptome analysis of fasudil treatment in the APPswe/PSEN1dE9 transgenic (APP/PS1) mice model of Alzheimer’s disease.
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-022-10554-9
– start-page: 860
  year: 2013
  ident: B28
  article-title: Xq22.3-q23 deletion including ACSL4 in a patient with intellectual disability.
  publication-title: Am. J. Med. Genet. A
  doi: 10.1002/ajmg.a.35778
– volume: 28
  start-page: 9
  ident: B62
  article-title: Promotion of glioma cell survival by acyl-CoA synthetase 5 under extracellular acidosis conditions.
  publication-title: Oncogene
  doi: 10.1038/onc.2008.355
– volume: 233
  start-page: 507
  year: 2008
  ident: B84
  article-title: Mammalian long-chain acyl-CoA synthetases.
  publication-title: Exp. Biol. Med. (Maywood)
  doi: 10.3181/0710-MR-287
– volume: 419
  start-page: 505
  year: 2012
  ident: B14
  article-title: A novel role of brain-type ACS4 isotype in neuronal differentiation.
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2012.02.046
– volume: 15
  year: 2022
  ident: B53
  article-title: Ferroptosis participates in neuron damage in experimental cerebral malaria and is partially induced by activated CD8(+) T cells.
  publication-title: Mol. Brain
  doi: 10.1186/s13041-022-00942-7
– volume: 115
  start-page: 12343
  year: 2018
  ident: B15
  article-title: ACSL6 is critical for maintaining brain DHA levels.
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
  doi: 10.1073/pnas.1817557115
– volume: 24
  start-page: 88
  year: 2022
  ident: B108
  article-title: PKCβII phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis.
  publication-title: Nat. Cell Biol.
  doi: 10.1038/s41556-021-00818-3
– volume: 13
  year: 2022
  ident: B109
  article-title: Sirtuin 2 alleviates chronic neuropathic pain by suppressing ferroptosis in rats.
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2022.827016
– volume: 115
  start-page: 12525
  year: 2018
  ident: B21
  article-title: Acyl-CoA synthetase 6 enriches the neuroprotective omega-3 fatty acid DHA in the brain.
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
  doi: 10.1073/pnas.1807958115
– volume: 12
  year: 2022
  ident: B99
  article-title: lncRNA PRADX is a mesenchymal glioblastoma biomarker for cellular metabolism targeted therapy.
  publication-title: Front. Oncol.
  doi: 10.3389/fonc.2022.888922
– volume: 24
  year: 2021
  ident: B83
  article-title: Apoferritin improves motor deficits in MPTP-treated mice by regulating brain iron metabolism and ferroptosis.
  publication-title: iScience
  doi: 10.1016/j.isci.2021.102431
– volume: 47
  start-page: 279
  year: 2022
  ident: B1
  article-title: Liraglutide alleviates cognitive deficit in db/db Mice: Involvement in oxidative stress, iron overload, and ferroptosis.
  publication-title: Neurochem. Res.
  doi: 10.1007/s11064-021-03442-7
– volume: 2020
  year: 2020
  ident: B103
  article-title: Antioxidants targeting mitochondrial oxidative stress: Promising neuroprotectants for epilepsy.
  publication-title: Oxid. Med. Cell. Longev.
  doi: 10.1155/2020/6687185
– volume: 22
  start-page: 266
  year: 2021
  ident: B40
  article-title: Ferroptosis: Mechanisms, biology and role in disease.
  publication-title: Nat. Rev. Mol. Cell Biol.
  doi: 10.1038/s41580-020-00324-8
– volume: 18
  start-page: 3894
  year: 2009
  ident: B110
  article-title: Analyses of mental dysfunction-related ACSl4 in Drosophila reveal its requirement for Dpp/BMP production and visual wiring in the brain.
  publication-title: Hum. Mol. Genet.
  doi: 10.1093/hmg/ddp332
– volume: 10
  year: 2022
  ident: B70
  article-title: Edaravone modulates neuronal GPX4/ACSL4/5-LOX to promote recovery after spinal cord injury.
  publication-title: Front. Cell Dev. Biol.
  doi: 10.3389/fcell.2022.849854
– volume: 43
  start-page: 147
  year: 2020
  ident: B12
  article-title: ACSL4 suppresses glioma cells proliferation via activating ferroptosis.
  publication-title: Oncol. Rep.
  doi: 10.3892/or.2019.7419
– volume: 280
  start-page: 10817
  year: 2005
  ident: B60
  article-title: Long-chain acyl-CoA synthetase 6 preferentially promotes DHA metabolism.
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M411750200
– volume: 52
  start-page: 782
  year: 2011
  ident: B29
  article-title: Long-chain acyl-CoA synthetase 4 modulates prostaglandin E2 release from human arterial smooth muscle cells.
  publication-title: J. Lipid Res.
  doi: 10.1194/jlr.M013292
– volume: 13
  year: 2022
  ident: B64
  article-title: Hsp90 induces Acsl4-dependent glioma ferroptosis via dephosphorylating Ser637 at Drp1.
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-022-04997-1
– volume: 29
  start-page: 43
  year: 2022
  ident: B80
  article-title: 3D two-photon brain imaging reveals dihydroartemisinin exerts antiepileptic effects by modulating iron homeostasis.
  publication-title: Cell Chem. Biol.
  doi: 10.1016/j.chembiol.2021.12.006
– volume: 2022
  year: 2022
  ident: B107
  article-title: Activation of SIRT1 alleviates ferroptosis in the early brain injury after subarachnoid hemorrhage.
  publication-title: Oxid. Med. Cell. Longev.
  doi: 10.1155/2022/9069825
– volume: 55
  start-page: 853
  year: 2021
  ident: B2
  article-title: MicroRNA-670-3p suppresses ferroptosis of human glioblastoma cells through targeting ACSL4.
  publication-title: Free Radic. Res.
  doi: 10.1080/10715762.2021.1962009
– volume: 99
  year: 2021
  ident: B26
  article-title: Tetrahydroxy stilbene glycoside ameliorates Alzheimer’s disease in APP/PS1 mice via glutathione peroxidase related ferroptosis.
  publication-title: Int. Immunopharmacol.
  doi: 10.1016/j.intimp.2021.108002
– volume: 366
  year: 2022
  ident: B50
  article-title: Baicalein ameliorates cerebral ischemia-reperfusion injury by inhibiting ferroptosis via regulating GPX4/ACSL4/ACSL3 axis.
  publication-title: Chem. Biol. Interact.
  doi: 10.1016/j.cbi.2022.110137
– volume: 58
  start-page: 884
  year: 2017
  ident: B46
  article-title: Long-chain acyl-CoA synthetase isoforms differ in preferences for eicosanoid species and long-chain fatty acids.
  publication-title: J. Lipid Res.
  doi: 10.1194/jlr.M072512
– volume: 11
  start-page: 2118
  year: 2021
  ident: B96
  article-title: Lipoxin A4 protects primary spinal cord neurons from Erastin-induced ferroptosis by activating the Akt/Nrf2/HO-1 signaling pathway.
  publication-title: FEBS Open Bio
  doi: 10.1002/2211-5463.13203
– volume: 19
  start-page: 5919
  year: 2000
  ident: B100
  article-title: Fatty acid induced glioma cell growth is mediated by the acyl-CoA synthetase 5 gene located on chromosome 10q25.1-q25.2, a region frequently deleted in malignant gliomas.
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1203981
– volume: 100
  start-page: 100
  year: 2019
  ident: B6
  article-title: An ACSL4 hemizygous intragenic deletion in a patient with childhood stroke.
  publication-title: Pediatr. Neurol.
  doi: 10.1016/j.pediatrneurol.2019.06.014
– volume: 47
  year: 2021
  ident: B32
  article-title: Carthamin yellow improves cerebral ischemia-reperfusion injury by attenuating inflammation and ferroptosis in rats.
  publication-title: Int. J. Mol. Med.
  doi: 10.3892/ijmm.2021.4885
– volume: 9
  year: 2020
  ident: B73
  article-title: Reduction of SCUBE3 by a new marine-derived asterosaponin leads to arrest of glioma cells in G1/S.
  publication-title: Oncogenesis
  doi: 10.1038/s41389-020-00252-4
– volume: 159
  start-page: 657
  year: 2009
  ident: B63
  article-title: The XLMR gene ACSL4 plays a role in dendritic spine architecture.
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2008.11.056
– volume: 179
  start-page: 109
  year: 2022
  ident: B10
  article-title: Ferrostatin-1 obviates seizures and associated cognitive deficits in ferric chloride-induced posttraumatic epilepsy via suppressing ferroptosis.
  publication-title: Free Radic. Biol. Med.
  doi: 10.1016/j.freeradbiomed.2021.12.268
– volume: 7
  year: 2022
  ident: B89
  article-title: Thrombin induces ACSL4-dependent ferroptosis during cerebral ischemia/reperfusion.
  publication-title: Signal Transduct. Target. Ther.
  doi: 10.1038/s41392-022-00917-z
– volume: 43
  start-page: 4231
  year: 2022
  ident: B4
  article-title: Common genetic basis of ALS patients and soccer players may contribute to disease risk.
  publication-title: Neurol. Sci.
  doi: 10.1007/s10072-022-05990-4
– volume: 18
  start-page: 960
  year: 2019
  ident: B112
  article-title: Integrated metabolomics and lipidomics analyses reveal metabolic reprogramming in human glioma with IDH1 mutation.
  publication-title: J. Proteome Res.
  doi: 10.1021/acs.jproteome.8b00663
– volume: 13
  start-page: 91
  year: 2017
  ident: B20
  article-title: ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition.
  publication-title: Nat. Chem. Biol.
  doi: 10.1038/nchembio.2239
– volume: 1821
  start-page: 358
  year: 2012
  ident: B43
  article-title: Acyl-CoA synthetase 1 is required for oleate and linoleate mediated inhibition of cholesterol efflux through ATP-binding cassette transporter A1 in macrophages.
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbalip.2011.10.008
– volume: 47
  start-page: 410
  year: 2019
  ident: B44
  article-title: Ferroptosis contributes to neuronal death and functional outcome after traumatic brain injury.
  publication-title: Crit. Care Med.
  doi: 10.1097/CCM.0000000000003555
– volume: 6
  start-page: 321
  year: 2013
  ident: B92
  article-title: Lipid metabolism genes in contralateral unaffected breast and estrogen receptor status of breast cancer.
  publication-title: Cancer Prev. Res. (Phila)
  doi: 10.1158/1940-6207.CAPR-12-0304
– volume: 93
  start-page: 312
  year: 2021
  ident: B18
  article-title: ACSL4 exacerbates ischemic stroke by promoting ferroptosis-induced brain injury and neuroinflammation.
  publication-title: Brain Behav. Immun.
  doi: 10.1016/j.bbi.2021.01.003
– volume: 12
  year: 2021
  ident: B3
  article-title: Prokineticin-2 prevents neuronal cell deaths in a model of traumatic brain injury.
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-021-24469-y
– volume: 29
  start-page: 1187
  year: 2022
  ident: B95
  article-title: Ferroptosis mediates selective motor neuron death in amyotrophic lateral sclerosis.
  publication-title: Cell Death Differ.
  doi: 10.1038/s41418-021-00910-z
– volume: 8
  start-page: 4733
  year: 2018
  ident: B94
  article-title: Mesenchymal glioblastoma constitutes a major ceRNA signature in the TGF-β pathway.
  publication-title: Theranostics
  doi: 10.7150/thno.26550
– volume: 73
  year: 2021
  ident: B51
  article-title: p53-mediated ferroptosis is required for 1-methyl-4-phenylpyridinium-induced senescence of PC12 cells.
  publication-title: Toxicol. Vitro
  doi: 10.1016/j.tiv.2021.105146
– volume: 34
  start-page: 2785
  year: 2014
  ident: B55
  article-title: dAcsl, the Drosophila ortholog of acyl-CoA synthetase long-chain family member 3 and 4, inhibits synapse growth by attenuating bone morphogenetic protein signaling via endocytic recycling.
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.3547-13.2014
– volume: 8
  year: 2021
  ident: B5
  article-title: Cox4i2 Triggers an increase in reactive oxygen species, leading to ferroptosis and apoptosis in HHV7 infected schwann cells.
  publication-title: Front. Mol. Biosci.
  doi: 10.3389/fmolb.2021.660072
– volume: 25
  start-page: 1227
  year: 2021
  ident: B33
  article-title: Inhibition of ferroptosis-like cell death attenuates neuropathic pain reactions induced by peripheral nerve injury in rats.
  publication-title: Eur. J. Pain
  doi: 10.1002/ejp.1737
– volume: 13
  year: 2013
  ident: B57
  article-title: Diversity and history of the long-chain acyl-CoA synthetase (Acsl) gene family in vertebrates.
  publication-title: BMC Evol. Biol.
  doi: 10.1186/1471-2148-13-271
– volume: 117
  start-page: 10155
  year: 2020
  ident: B81
  article-title: Epileptic brain fluorescent imaging reveals apigenin can relieve the myeloperoxidase-mediated oxidative stress and inhibit ferroptosis.
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
  doi: 10.1073/pnas.1917946117
– volume: 107
  year: 2020
  ident: B111
  article-title: Proanthocyanidin promotes functional recovery of spinal cord injury via inhibiting ferroptosis.
  publication-title: J. Chem. Neuroanat.
  doi: 10.1016/j.jchemneu.2020.101807
– volume: 747
  year: 2021
  ident: B104
  article-title: Role of ferroptosis in neurological diseases.
  publication-title: Neurosci. Lett.
  doi: 10.1016/j.neulet.2020.135614
– volume: 28
  start-page: 2029
  year: 2021
  ident: B67
  article-title: Molecular mechanisms of cell death in neurological diseases.
  publication-title: Cell Death Differ.
  doi: 10.1038/s41418-021-00814-y
SSID ssj0062842
Score 2.386967
SecondaryResourceType review_article
Snippet Long-chain acyl-coenzyme A synthetases (ACSLs) are a family of CoA synthetases that activate fatty acid (FA) with chain lengths of 12–20 carbon atoms by...
Long-chain acyl-coenzyme A synthetases (ACSLs) are a family of CoA synthetases that activate fatty acid (FA) with chain lengths of 12-20 carbon atoms by...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1030512
SubjectTerms fatty acid (FA) metabolism
ferroptosis
long-chain acyl-coenzyme A synthetases (ACSLs)
nervous system diseases
Neuroscience
targeted therapy
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYhp1xC2ySt-wgqlFyCiF6W7OO2NIRCekogN6Fns7CRQ3b3sP31HdneZTeE9tKrZWExM9J8nzUPhL443zrlQyTB1p5IqylxyTtiZQL6nKjnvCQ4X_9UV7fyx119t9Xqq8SEDeWBB8FdaNumWifOvJBAXairha4TeEUXpWJ9f2EOPm9NpoYzWMGhy4cUGaBg7UXK01xqc3NekszBDvmOG-qr9b8EMZ9HSm65nstX6HDEjHgyrPU12ov5DTqaZODLDyt8hvsozv73-BHKk4yXj4XG4y5jQHd4K8MKT7fix3GX8KzLv4i_t9OMrV_NiO9i_r16iHiC56sMMxfg5OYYhjOcKd1yjofKz3i815kfo9vL7zffrsjYU4F4qZoFiTxF2aYmUVsHGlkAeFgH3TIRrOOJtkHL0Hhqg0jMMksTMB4lbcExpVmVOEH7ucvxHcI6Nsl7ARRSUOlkbCxzXjTcq6AcC3WF2FrExo8Fx0vfi5kB4lHUYnq1mKIWM6qlQuebOY9DuY2_vv21aG7zZimV3T8AAzKjAZl_GVCFPq_1bmBrlfsSmyNI1HCgcko1bSMq9Hawg82nBCBbDVitQnrHQnbWsjuSp_d9-e7SLAxw9_v_sfgP6KAIpCRHcvkR7S-elvEToKSFO-03xB_VHhII
  priority: 102
  providerName: Directory of Open Access Journals
Title An update on the therapeutic implications of long-chain acyl-coenzyme A synthetases in nervous system diseases
URI https://www.ncbi.nlm.nih.gov/pubmed/36507355
https://www.proquest.com/docview/2753668983
https://pubmed.ncbi.nlm.nih.gov/PMC9731139
https://doaj.org/article/7a9f57f21c344460b5375f028be46112
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqcuGCgPLYUiojIS4oED9iJweEFkSpkMqJlfYW-dmutHXKPiTSX89Mkl3tosKBSw7xI5HH4_k-2zNDyGvrKqucD5k3hcuk0Xlmo7OZkRHoc8wd5-jgfPFdnU_kt2kxPSCbdEfDAC7vpHaYT2qymL_79bP9CAr_ARkn2Nv3Mc0SRt7mHF3IYZbBknwPLJNGRb2Q21MFBUtxd_qp0FMIoHrvRPOXPvYMVRfP_y4Q-uddyh3jdPaQPBhQJR330-AROQjpMTkaJ2DU1y19Q7t7nt0G-hFJ40TXN0j0aZMo4D-644NFZzs3zGkT6bxJl5m7MrNEjWvnmWtCum2vAx3TZZug5QrM4JJCcYJVp1kvaR8bmg4nP8snZHL25cfn82zIupA5qcpVFngMsoplzE3h88A8AMjC64oJbyyPeeW19KXLjReRGWbyCJxISYNIB9NZiafkMDUpPCdUhzI6J4BkilxaGUrDrBMld8ory3wxImwzxLUbQpJjZox5DdQExVJ3YqlRLPUglhF5u21z0wfk-GftTyi5bU0Mpt29aBaX9aCbtTZVLHTkzAkJ7Di3hdBFBOBlg1QMO3m1kXsNyocnKiYFGNGaA9lTqqxKMSLP-nmw_ZQA7KsBzY2I3pshe_-yX5JmV12Ab0wnBsj8-L9bviD3cRTQZ5LLE3K4WqzDSwBPK3vabTrA8-uUnXba8RvwVh5j
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=An+update+on+the+therapeutic+implications+of+long-chain+acyl-coenzyme+A+synthetases+in+nervous+system+diseases&rft.jtitle=Frontiers+in+neuroscience&rft.au=Wu%2C+Zhimin&rft.au=Sun%2C+Jun&rft.au=Liao%2C+Zhi&rft.au=Qiao%2C+Jia&rft.date=2022-11-24&rft.pub=Frontiers+Media+S.A&rft.issn=1662-4548&rft.eissn=1662-453X&rft.volume=16&rft_id=info:doi/10.3389%2Ffnins.2022.1030512&rft.externalDocID=PMC9731139
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1662-453X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1662-453X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1662-453X&client=summon